Siemens Healthineers AG (CHIX:SHLD) FCF Margin %: 17.75% (As of Jun. 2026) — 87% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:SHLD Siemens Healthineers AG CHIX:SHLD
81 GF Score
Price €39.08
GF Value €51.61
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Siemens Healthineers AG FCF Margin %?

Siemens Healthineers AG CHIX:SHLD 81 FCF Margin % is 17.75% as of Jun. 2026, which is 87% above its 10-year median of 9.50. GuruFocus rates CHIX:SHLD with a GF Score™ of 81/100 and a GF Value™ of €51.61 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Siemens Healthineers AG ranks better than 77.15% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Siemens Healthineers AG's Free Cash Flow for the three months ended in Jun. 2026 was €1,023 Mil. Siemens Healthineers AG's Revenue for the three months ended in Jun. 2026 was €5,764 Mil. Therefore, Siemens Healthineers AG's FCF Margin % for the quarter that ended in Jun. 2026 was 17.75%.

As of today, Siemens Healthineers AG's current FCF Yield % is 5.93%.

The historical rank and industry rank for Siemens Healthineers AG's FCF Margin % or its related term are showing as below:

CHIX:SHLd' s FCF Margin % Range Over the Past 10 Years
Min: 5.91   Med: 9.5   Max: 12.55
Current: 11.25


During the past 11 years, the highest FCF Margin % of Siemens Healthineers AG was 12.55%. The lowest was 5.91%. And the median was 9.50%.

CHIX:SHLd's FCF Margin % is ranked better than
77.15% of 814 companies
in the Medical Devices & Instruments industry
Industry Median: -0.705 vs CHIX:SHLd: 11.25


Siemens Healthineers AG FCF Margin % Related Terms


Siemens Healthineers AG FCF Margin % Historical Data

* Premium members only.

The historical data trend for Siemens Healthineers AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siemens Healthineers AG FCF Margin % Chart

Siemens Healthineers AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.55 7.61 5.91 9.52 11.61

Siemens Healthineers AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.91 13.65 6.13 6.85 17.75

CHIX:SHLD vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Siemens Healthineers AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's FCF Margin % falls into.


CHIX:SHLD
81GF Score
Siemens Healthineers AG CHIX:SHLD
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siemens Healthineers AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Siemens Healthineers AG's FCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=2714/23375
=11.61 %

Siemens Healthineers AG's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=1023/5764
=17.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 17.75% mean?
Siemens Healthineers AG (CHIX:SHLD) has a FCF Margin % of 17.75% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Siemens Healthineers AG and its competitors. This is 87% above median its historical median of 9.50. Over the past decade, Siemens Healthineers AG's FCF Margin % has ranged from 5.91 to 12.55. According to the industry distribution chart, Siemens Healthineers AG ranks #186 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 22.9%.
Is Siemens Healthineers AG's FCF Margin % too high?
Siemens Healthineers AG's current FCF Margin % of 17.75% is 87% above median its 10-year median of 9.50. Over the past 10 years, this metric has ranged from a low of 5.91 to a high of 12.55. Based on the distribution chart, Siemens Healthineers AG ranks #186 out of 814 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Siemens Healthineers AG has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #186 out of 814 companies for FCF Margin %. This places Siemens Healthineers AG in the top 23% of its industry — outperforming the majority of peers. Historically, Siemens Healthineers AG's own FCF Margin % has ranged from 5.91 to 12.55 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Siemens Healthineers AG and its competitors. Siemens Healthineers AG's current FCF Margin % is 17.75%, which is 87% above median its own 10-year median of 9.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (CHIX:SHLD) is currently considered Modestly Undervalued. The stock's GF Value™ is €51.61, compared to a current price of €39.08 — trading 24.3% below its estimated fair value. The current FCF Margin % is 17.75%, which is 87% above median its 10-year median of 9.50. Siemens Healthineers AG's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Siemens Healthineers AG (CHIX:SHLD), the current FCF Margin % is 17.75% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (CHIX:SHLD) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of €39.08 is trading 24.3% below its estimated GF Value™ of €51.61. GuruFocus considers Siemens Healthineers AG to be Modestly Undervalued.

Key valuation signals for CHIX:SHLD:

  • FCF Margin %: 17.75% (87% above median its 10-year median of 9.50)
  • GF Value™: €51.61 vs. price of €39.08 (24.3% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the CHIX:SHLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
81GF Score

Get the complete analysis for CHIX:SHLD

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.08
Price
€51.61
GF Value